These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37098506)

  • 1. Problem gambling among people with first-episode psychosis: protocol for a prospective multicenter cohort study.
    Corbeil O; Soulard M; Huot-Lavoie M; Béchard L; Fournier É; Brodeur S; Essiambre AM; Desmeules C; Thériault C; Abdel-Baki A; Jacques C; Giroux I; Dorval M; Roy MA; Demers MF
    BMC Psychiatry; 2023 Apr; 23(1):287. PubMed ID: 37098506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program.
    Corbeil O; Corbeil S; Dorval M; Carmichael PH; Giroux I; Jacques C; Demers MF; Roy MA
    CNS Drugs; 2021 Apr; 35(4):461-468. PubMed ID: 33713298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCT.
    Morrison AP; Pyle M; Byrne R; Broome M; Freeman D; Johns L; James A; Husain N; Whale R; MacLennan G; Norrie J; Hudson J; Peters S; Davies L; Bowe S; Smith J; Shiers D; Joyce E; Jones W; Hollis C; Maughan D
    Health Technol Assess; 2021 Jan; 25(4):1-124. PubMed ID: 33496261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone.
    Gómez-Revuelta M; Pelayo-Terán JM; Juncal-Ruiz M; Vázquez-Bourgon J; Suárez-Pinilla P; Romero-Jiménez R; Setién Suero E; Ayesa-Arriola R; Crespo-Facorro B
    Int J Neuropsychopharmacol; 2020 Apr; 23(4):217-229. PubMed ID: 31974576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problem Gambling Associated With Aripiprazole in First-Episode Psychosis Patients: A Series of 6 Case Reports.
    Corbeil O; Corbeil S; Giroux I; Jacques C; Dorval M; Demers MF; Roy MA
    J Clin Psychopharmacol; 2020; 40(2):191-194. PubMed ID: 32134855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and correlates of problem gambling in people with psychotic disorders.
    Haydock M; Cowlishaw S; Harvey C; Castle D
    Compr Psychiatry; 2015 Apr; 58():122-9. PubMed ID: 25684263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hummingbird Study: a study protocol for a multicentre exploratory trial to assess the acceptance and performance of a digital medicine system in adults with schizophrenia, schizoaffective disorder or first-episode psychosis.
    Fowler JC; Cope N; Knights J; Phiri P; Makin A; Peters-Strickland T; Rathod S
    BMJ Open; 2019 Jun; 9(6):e025952. PubMed ID: 31253613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Antipsychotic Effectiveness in First Episode of Psychosis: A 3-Year Follow-Up Randomized Clinical Trial Comparing Aripiprazole, Quetiapine, and Ziprasidone.
    Gómez-Revuelta M; Pelayo-Terán JM; Juncal-Ruiz M; Ortiz-García de la Foz V; Vázquez-Bourgon J; González-Pinto A; Crespo-Facorro B
    Int J Neuropsychopharmacol; 2018 Dec; 21(12):1090-1101. PubMed ID: 30215723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
    Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
    Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
    Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MG; Bilenberg N; Stenstrøm AD; Nyvang L; Madsen S; Werge TM; Lange T; Gluud C; Skoog M; Winkel P; Jepsen JRM; Fagerlund B; Correll CU; Fink-Jensen A
    Lancet Psychiatry; 2017 Aug; 4(8):605-618. PubMed ID: 28599949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis patients.
    Vázquez-Bourgon J; Ibáñez Alario M; Mayoral-van Son J; Gómez Revuelta M; Ayesa Arriola R; Juncal Ruiz M; Ortiz-García de la Foz V; Crespo Facorro B
    Eur Neuropsychopharmacol; 2020 Oct; 39():46-55. PubMed ID: 32891516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.
    Weller A; Gleeson J; Alvarez-Jimenez M; McGorry P; Nelson B; Allott K; Bendall S; Bartholomeusz C; Koval P; Harrigan S; O'Donoghue B; Fornito A; Pantelis C; Paul Amminger G; Ratheesh A; Polari A; Wood SJ; van der El K; Ellinghaus C; Gates J; O'Connell J; Mueller M; Wunderink L; Killackey E
    Early Interv Psychiatry; 2019 Dec; 13(6):1345-1356. PubMed ID: 30488637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14-18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS).
    Pyle M; Broome MR; Joyce E; MacLennan G; Norrie J; Freeman D; Fowler D; Haddad PM; Shiers D; Hollis C; Smith J; Liew A; Byrne RE; French P; Peters S; Hudson J; Davies L; Emsley R; Yung A; Birchwood M; Longden E; Morrison AP
    Trials; 2019 Jul; 20(1):395. PubMed ID: 31272477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: a 12-week randomized, flexible-dose, open-label trial.
    Crespo-Facorro B; Ortiz-García de la Foz V; Mata I; Ayesa-Arriola R; Suarez-Pinilla P; Valdizan EM; Vázquez-Barquero JL; Pérez-Iglesias R
    Schizophr Res; 2013 Jul; 147(2-3):375-82. PubMed ID: 23643328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effectiveness and tolerability of aripiprazole as initial choice of treatment in first episode psychosis in an early intervention service: A one-year outcome study.
    Malla A; Mustafa S; Rho A; Abadi S; Lepage M; Joober R
    Schizophr Res; 2016 Jul; 174(1-3):120-125. PubMed ID: 27157800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
    Begemann MJH; Thompson IA; Veling W; Gangadin SS; Geraets CNW; van 't Hag E; Müller-Kuperus SJ; Oomen PP; Voppel AE; van der Gaag M; Kikkert MJ; Van Os J; Smit HFE; Knegtering RH; Wiersma S; Stouten LH; Gijsman HJ; Wunderink L; Staring ABP; Veerman SRT; Mahabir AGS; Kurkamp J; Pijnenborg GHM; Veen ND; Marcelis M; Grootens KP; Faber G; van Beveren NJ; Been A; van den Brink T; Bak M; van Amelsvoort TAMJ; Ruissen A; Blanke C; Groen K; de Haan L; Sommer IEC
    Trials; 2020 Feb; 21(1):147. PubMed ID: 32033579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.
    Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
    Lancet Psychiatry; 2017 Aug; 4(8):627-633. PubMed ID: 28705600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between problem gambling and psychotic experiences: Findings from the Adult Psychiatric Morbidity Survey 2007.
    Jacob L; Haro JM; Koyanagi A
    Schizophr Res; 2018 Nov; 201():79-84. PubMed ID: 29804926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.